These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 2230448

  • 1. [Studies on usefulness of postoperative adjuvant chemotherapy with lentinan in patients with gastrointestinal cancer].
    Tanabe H, Imai N, Takechi K.
    Nihon Gan Chiryo Gakkai Shi; 1990 Aug 20; 25(8):1657-67. PubMed ID: 2230448
    [Abstract] [Full Text] [Related]

  • 2. Study of effect of surgical stress on immunity in patients with gastrointestinal cancer.
    Tanabe H.
    Nihon Geka Hokan; 1993 May 01; 62(3):145-52. PubMed ID: 8274052
    [Abstract] [Full Text] [Related]

  • 3. Usefulness of lymphocyte subset change as an indicator for predicting survival time and effectiveness of treatment with the immunopotentiator lentinan.
    Matsuoka H, Yano K, Seo Y, Saito T, Tomoda H, Tsurumoto S.
    Anticancer Res; 1995 May 01; 15(5B):2291-6. PubMed ID: 8572640
    [Abstract] [Full Text] [Related]

  • 4. [Effects of endoscopic intratumoral injection of lentinan in patients with gastric cancer].
    Inagaki T, Morise K, Matsunaga H.
    Gan To Kagaku Ryoho; 1988 Feb 01; 15(2):319-24. PubMed ID: 3257678
    [Abstract] [Full Text] [Related]

  • 5. [Effect of lentinan for advanced prostate carcinoma].
    Tari K, Satake I, Nakagomi K, Ozawa K, Oowada F, Higashi Y, Negishi T, Yamada T, Saito H, Yoshida K.
    Hinyokika Kiyo; 1994 Feb 01; 40(2):119-23. PubMed ID: 8128920
    [Abstract] [Full Text] [Related]

  • 6. [Provision for adverse effect of S-1 containing chemotherapy in patients with advanced digestive cancer--combination with superfine dispersed lentinan].
    Yagi M, Watanabe S, Yoshino S, Hazama S, Suga T, Nakazawa S.
    Gan To Kagaku Ryoho; 2010 Mar 01; 37(3):457-62. PubMed ID: 20332683
    [Abstract] [Full Text] [Related]

  • 7. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G, Spuzić I.
    Srp Arh Celok Lek; 1995 Mar 01; 123(9-10):227-31. PubMed ID: 17974436
    [Abstract] [Full Text] [Related]

  • 8. [Results of phase III study of lentinan].
    Taguchi T, Furue H, Kimura T, Kondo T, Hattori T, Itoh I, Ogawa N.
    Gan To Kagaku Ryoho; 1985 Feb 01; 12(2):366-78. PubMed ID: 3918510
    [Abstract] [Full Text] [Related]

  • 9. [Effect of intrapleural and/or intraperitoneal lentinan therapy in carcinomatous pleuritis and peritonitis].
    Yoshino S, Oka M, Hazama S, Suzuki T.
    Gan To Kagaku Ryoho; 1990 Aug 01; 17(8 Pt 2):1588-91. PubMed ID: 2389953
    [Abstract] [Full Text] [Related]

  • 10. [Efficacy of Lentinan combined with chemotherapy in advanced non-small cell lung cancer].
    Wang W, Dai X, Ouyang X.
    Zhongguo Fei Ai Za Zhi; 2006 Feb 20; 9(1):78-81. PubMed ID: 21144289
    [Abstract] [Full Text] [Related]

  • 11. [Effects of lentinan in advanced or recurrent cases of gastric, colorectal, and breast cancer].
    Taguchi T.
    Gan To Kagaku Ryoho; 1983 Feb 20; 10(2 Pt 2):387-93. PubMed ID: 6349538
    [Abstract] [Full Text] [Related]

  • 12. [Effect of intrapleural and/or intraperitoneal lentinan therapy on carcinomatous pleuritis and peritonitis with special reference to immunological evaluation].
    Yoshino S, Oka M, Hazama S, Suzuki T.
    Nihon Geka Hokan; 1989 May 01; 58(3):310-9. PubMed ID: 2619436
    [Abstract] [Full Text] [Related]

  • 13. [Immunological study of the postoperative adjuvant treatment with interferon gamma in patients with renal cell cancer--measurement of peripheral blood lymphocyte subsets with three color flow cytometry].
    Yasunaga Y, Nishimura K, Miura H, Takatera H, Kuroda H, Kishimoto T, Fujioka H.
    Hinyokika Kiyo; 1995 Feb 01; 41(2):85-92. PubMed ID: 7702012
    [Abstract] [Full Text] [Related]

  • 14. [Studies on immunological parameters in patients with gastric carcinoma--with special reference to analyses with monoclonal antibodies of T-lymphocyte subsets and interleukin-2].
    Takeshita M, Ohwada S, Nakamura S, Miyamoto Y, Izuo M.
    Nihon Geka Gakkai Zasshi; 1987 Aug 01; 88(8):947-54. PubMed ID: 3501068
    [Abstract] [Full Text] [Related]

  • 15. [A comparative clinical trial with tegafur plus lentinan treatment at two different doses in advanced cancer].
    Wada T, Nishide T, Hatayama K, Chang SW, Tatsuta M, Yasutomi M.
    Gan To Kagaku Ryoho; 1987 Aug 01; 14(8):2509-12. PubMed ID: 3113339
    [Abstract] [Full Text] [Related]

  • 16. Effects of oral lentinan on T-cell subsets in peripheral venous blood.
    Hanaue H, Tokuda Y, Machimura T, Kamijoh A, Kondo Y, Ogoshi K, Makuuchi H, Nakasaki H, Tajima T, Mitomi T.
    Clin Ther; 1989 Aug 01; 11(5):614-22. PubMed ID: 2529966
    [Abstract] [Full Text] [Related]

  • 17. T-lymphocyte subsets in primary lung cancer.
    Tsuyuguchi I, Shiratsuchi H, Fukuoka M.
    Jpn J Clin Oncol; 1987 Mar 01; 17(1):13-7. PubMed ID: 3494139
    [Abstract] [Full Text] [Related]

  • 18. Lymphocytic subpopulation changes after open and laparoscopic cholecystectomy: a prospective and comparative study on 38 patients.
    Cristaldi M, Rovati M, Elli M, Gerlinzani S, Lesma A, Balzarotti L, Taschieri AM.
    Surg Laparosc Endosc; 1997 Jun 01; 7(3):255-61. PubMed ID: 9194291
    [Abstract] [Full Text] [Related]

  • 19. [Studies on the effect of lentinan on human immune system. II. In vivo effect on NK activity, MLR induced killer activity and PHA induced blastic response of lymphocytes in cancer patients].
    Amino M, Noguchi R, Yata J, Matsumura J, Hirayama R, Abe O, Enomoto K, Asato Y.
    Gan To Kagaku Ryoho; 1983 Sep 01; 10(9):2000-6. PubMed ID: 6225393
    [Abstract] [Full Text] [Related]

  • 20. [A clinical study of immunological status in gastric cancer patients--with special reference to T-cell subsets in the lymphocytes of regional lymph nodes].
    Ohwada S, Takeshita M, Miyamoto Y, Izumi M.
    Nihon Geka Gakkai Zasshi; 1990 Oct 01; 91(10):1560-6. PubMed ID: 2263239
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.